{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:24:33Z","timestamp":1783099473901,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803834"],"award-info":[{"award-number":["81803834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302837"],"award-info":[{"award-number":["81302837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.fct.2026.116113","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:35:30Z","timestamp":1777332930000},"page":"116113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TLR4 knockout ameliorates acute LPS-sensitized tolvaptan-induced idiosyncratic liver injury by disrupting drug metabolism, inflammation, and bile acid homeostasis"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-1809","authenticated-orcid":false,"given":"Xin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-lan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Meng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-qin","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-geng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2026.116113_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2022.08.012","article-title":"Clinical pattern of tolvaptan-associated liver injury in trial participants with autosomal dominant polycystic kidney disease (adpkd): an analysis of pivotal clinical trials","volume":"81","author":"Alpers","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.fct.2026.116113_bib2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.300.2.460","article-title":"Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?","volume":"300","author":"Buchweitz","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.fct.2026.116113_bib3","article-title":"Purification of hepatocytes and sinusoidal endothelial cells from mouse liver perfusion","volume":"12","author":"Cabral","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.fct.2026.116113_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2026.116113_bib5","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","article-title":"Deletion of tlr4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.fct.2026.116113_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.fct.2026.116113_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2026.116113_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2026.116113_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2004.09.002","article-title":"Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor","volume":"150","author":"Ganey","year":"2004","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2026.116113_bib10","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2026.116113_bib11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfaf048","article-title":"The long-term effect of tolvaptan treatment on kidney function and volume in patients with adpkd","volume":"40","author":"Geertsema","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.fct.2026.116113_bib12","doi-asserted-by":"crossref","first-page":"G434","DOI":"10.1152\/ajpgi.00562.2004","article-title":"Toll-like receptor-4 regulation of hepatic cyp3a11 metabolism in a mouse model of lps-induced cns inflammation","volume":"289","author":"Goralski","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2026.116113_bib13","article-title":"Pattern-recognition receptors in endometriosis: a narrative review","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2026.116113_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/toxsci\/kfae142","article-title":"Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities","volume":"203","author":"Hammond","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib15","first-page":"361","article-title":"Effect of inflammation on molecular targets and drug transporters","volume":"15","author":"Hanafy","year":"2012","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib16","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/AAC.00854-16","article-title":"Role of inflammatory and oxidative stress, cytochrome p450 2e1, and bile acid disturbance in rat liver injury induced by isoniazid and lipopolysaccharide cotreatment","volume":"60","author":"Hassan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2026.116113_bib17","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/AAC.00854-16","article-title":"Role of inflammatory and oxidative stress, cytochrome p450 2e1, and bile acid disturbance in rat liver injury induced by isoniazid and lipopolysaccharide cotreatment","volume":"60","author":"Hassan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2026.116113_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00216-024-05668-0","article-title":"Rapid quantification of murine bile acids using liquid chromatography-tandem mass spectrometry","volume":"417","author":"Hermeling","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.fct.2026.116113_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jpba.2011.03.035","article-title":"Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using lc-ms\/ms","volume":"55","author":"Huang","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.fct.2026.116113_bib20","article-title":"Tolvaptan-induced liver injury: who is at risk? A case report and literature review","volume":"11","author":"Khan","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.fct.2026.116113_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3904\/kjim.2022.376","article-title":"Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease","volume":"38","author":"Kim","year":"2023","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.fct.2026.116113_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1744-9987.12458","article-title":"Toll-like receptors in the progression of autosomal dominant polycystic kidney disease","volume":"20","author":"Kocyigit","year":"2016","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.fct.2026.116113_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines5040034","article-title":"Tlr4 signaling pathway modulators as potential therapeutics in inflammation and sepsis","volume":"5","author":"Kuzmich","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.fct.2026.116113_bib24","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1002\/pmic.201000327","article-title":"Protein abundances are more conserved than mrna abundances across diverse taxa","volume":"10","author":"Laurent","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.fct.2026.116113_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/toxsci\/kfr266","article-title":"Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha","volume":"125","author":"Lu","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/toxsci\/kft221","article-title":"Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents","volume":"137","author":"Luo","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.103.054288","article-title":"Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats","volume":"307","author":"Luyendyk","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.fct.2026.116113_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/15376516.2024.2332613","article-title":"Drug reactive metabolite-induced hepatotoxicity: a comprehensive review","volume":"34","author":"Mahajan","year":"2024","journal-title":"Toxicol. Mech. Methods"},{"issue":"2","key":"10.1016\/j.fct.2026.116113_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ijms21020379","article-title":"Recent advances in lipopolysaccharide recognition systems","volume":"21","author":"Mazgaeen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2008.156307","article-title":"Toll-like receptors as targets in chronic liver diseases","volume":"58","author":"Mencin","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.fct.2026.116113_bib31","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1124\/dmd.108.022632","article-title":"Lipopolysaccharide increases cell surface p-glycoprotein that exhibits diminished activity in intestinal epithelial cells","volume":"36","author":"Mishra","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2026.116113_bib32","first-page":"438","article-title":"Candidate risk factors and mechanisms for tolvaptan-induced liver injury are identified using a collaborative cross approach","volume":"156","author":"Mosedale","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.105010","article-title":"Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury","volume":"70","author":"Nautiyal","year":"2021","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2026.116113_bib34","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.00543.2022","article-title":"Endothelial mechanisms for inactivation of inflammation-induced hyperpermeability","volume":"324","author":"Nepali","year":"2023","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.fct.2026.116113_bib35","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1007\/s10557-011-6356-y","article-title":"Nonclinical safety profile of tolvaptan","volume":"25","author":"Oi","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.fct.2026.116113_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13643-023-02293-3","article-title":"Tolvaptan for water retention in heart failure: a systematic review","volume":"12","author":"Pan","year":"2023","journal-title":"Syst. Rev."},{"key":"10.1016\/j.fct.2026.116113_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.7.2.10","article-title":"Regulation of drug transporters during infection and inflammation","volume":"7","author":"Petrovic","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.fct.2026.116113_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.109.162651","article-title":"Intrinsic versus idiosyncratic drug-induced hepatotoxicity-two villains or one?","volume":"332","author":"Roth","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.fct.2026.116113_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/17425255.2020.1760246","article-title":"What have we learned from animal models of idiosyncratic, drug-induced liver injury?","volume":"16","author":"Roth","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.fct.2026.116113_bib40","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (idili): moving towards prediction","volume":"11","author":"Segovia-Zafra","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.fct.2026.116113_bib41","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.ekir.2025.03.020","article-title":"Kidney function trajectories with tolvaptan in adpkd patients with ckd-g5","volume":"10","author":"Sekine","year":"2025","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.fct.2026.116113_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/lt.23655","article-title":"Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure","volume":"19","author":"Shah","year":"2013","journal-title":"Liver Transplant."},{"key":"10.1016\/j.fct.2026.116113_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/toxsci\/kfv231","article-title":"Inhibition of human hepatic bile acid transporters by tolvaptan and metabolites: contributing factors to drug-induced liver injury?","volume":"149","author":"Slizgi","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/toxsci\/kfr177","article-title":"Dose-response of five bile acids on serum and liver bile acid concentrations and hepatotoxicty in mice","volume":"123","author":"Song","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13730-022-00767-2","article-title":"Microbiome of infected cysts, feces and saliva in patients with autosomal dominant polycystic kidney disease","volume":"12","author":"Suwabe","year":"2023","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.fct.2026.116113_bib46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40264-015-0327-3","article-title":"Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database","volume":"38","author":"Watkins","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.fct.2026.116113_bib47","doi-asserted-by":"crossref","first-page":"G668","DOI":"10.1152\/ajpgi.00026.2018","article-title":"Biliverdin reductase and bilirubin in hepatic disease","volume":"314","author":"Weaver","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2026.116113_bib48","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.34067\/KID.0000000836","article-title":"The gut microbiome in autosomal dominant polycystic kidney disease: a cross-sectional study","volume":"6","author":"Woestmann","year":"2025","journal-title":"Kidney"},{"key":"10.1016\/j.fct.2026.116113_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfw193","article-title":"Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors","volume":"155","author":"Woodhead","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s40495-018-0147-0","article-title":"Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity","volume":"4","author":"Woolbright","year":"2018","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.fct.2026.116113_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jfda.2018.11.005","article-title":"The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: evidences in inflammatory diseases and age-related disorders","volume":"27","author":"Wu","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.fct.2026.116113_bib52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bcp.2015.03.015","article-title":"Mechanisms of tolvaptan-induced toxicity in hepg2 cells","volume":"95","author":"Wu","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.fct.2026.116113_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2026.116113_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","article-title":"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases","volume":"24","author":"Yang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.fct.2026.116113_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105374","article-title":"Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization","volume":"82","author":"Yang","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.fct.2026.116113_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol. Pharm."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526001870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526001870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:05:54Z","timestamp":1783098354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691526001870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"alternative-id":["S0278691526001870"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2026.116113","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4 knockout ameliorates acute LPS-sensitized tolvaptan-induced idiosyncratic liver injury by disrupting drug metabolism, inflammation, and bile acid homeostasis","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2026.116113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116113"}}